CVC buys 143,889 Recordati shares. Recordati stock nears EUR 53 offer

Published on 10/20/2026 at 09:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Respighi BidCo extended its EUR 53.00 offer to October 23, 2026. Recordati stock costs EUR 53.03 on October 20, 2026.

Takeover timetable and ownership

CVC acquired 143,889 Recordati shares on October 16, 2026.
The tender offer ends on October 23, 2026, and third-quarter results are due on November 10, 2026.
Recordati stock traded at EUR 53.03 at 9:44 a.m. CEST at Lang & Schwarz on October 20, 2026.

Flatlay mit Aktienzertifikat, ISIN-Karte, Tabletten und Stethoskop auf Holztisch — Recordati S.p.A. (IT0003828271) symbolisiert dieses Flatlay mit Aktienzertifikat, ISIN-Karte und typischen Pharma-Utensilien, Illustration mit AI erstellt.

Recordati (ISIN IT0003828271) saw CVC acquire 143,889 shares on October 16, 2026, while Recordati stock was trading at EUR 53.03 at Lang & Schwarz on October 20, 2026 at 9:44 a.m. CEST, against the EUR 53.00 takeover offer. TipRanks reported that the purchase lifted CVC's direct stake to 3.58 percent, alongside additional exposure through derivatives.

Offer terms set the timetable

Recordati published the revised offer terms on October 6, 2026. Respighi BidCo raised the consideration from EUR 51.29 to EUR 53.00 per share and extended the acceptance period to October 23, 2026. Reuters said the vehicle is backed by CVC Capital Partners and Groupe Bruxelles Lambert and plans to delist Recordati from the Milan exchange.

The revised offer also includes the EUR 0.71 dividend already distributed for 2025, taking the total consideration to EUR 53.71 per share, according to Reuters. For shareholders, the narrow gap between the market indication and the cash offer leaves the bid timetable as the immediate trading reference.

What changes before the deadline?

The chronology is clear: on October 6, 2026, Respighi BidCo lifted the offer to EUR 53.00 per share; on October 14, 2026, Palliser Capital sought clarification on the independent directors' view of that price; and on October 16, 2026, CVC bought 143,889 shares at up to EUR 53.00, according to TipRanks.

The next dates are October 23, 2026, when the acceptance period ends, and November 10, 2026, when Recordati's third-quarter results are scheduled, according to Marketscreener. Recordati describes itself as a pharmaceutical company listed on the Italian stock exchange, with more than 4,700 employees and operations in around 150 countries, according to its investor-relations page.

Offer price anchors the stock

The stock was trading at EUR 53.03 at Lang & Schwarz on October 20, 2026 at 9:44 a.m. CEST, compared with the EUR 53.00 cash offer. The further course of trading is shown by the continuously updated real-time quote of Recordati stock.